
Private Equity
Hybrid Capital
Mergers & Acquisitions
Banking & Finance
John Miller is a partner at Latham & Watkins in Boston, where he serves as the Global Vice Chair of the firm's Hybrid Capital Practice. With extensive experience in private equity and hybrid capital transactions, John provides strategic advice to private capital clients on complex investments and acquisitions. His expertise spans leveraged buyouts, preferred equity financings, and venture capital financings. John has a proven track record of delivering innovative solutions for clients across various industries, drawing on his deep market knowledge and experience in sophisticated financial instruments.
John Miller's representative experience includes advising:
- Morgan Stanley Tactical Value acted as the acquirer in this Growth Investment transaction. - The acquisition targeted assets operating in the Fintech sector. - The transaction was announced on 22 Jul 2024 with a reported value of 1000000000.0.
Jul 22 2024
100M
Private Equity
Partner
2022 – Unknown
Associate
2019 – 2022
Associate
2018 – 2019
Associate
2011 – 2018
- K2 Medical Research acquired K2 Medical Research from K2 Medical Research in a private equity on 2024-06-20. - Deal value was 500000000 (source: AI Estimation) Ownership: significant strategic growth investment; Sector: Healthcare; Location: USA. - On the acquirer side, Latham & Watkins advised, led by John Miller, Justin Hamill, Michael Benjamin.
Jun 20 2024
500M
Private Equity
Judicial Intern
2010 – 2010
Research Assistant
2009 – 2010